Doximity, Inc. (NASDAQ:DOCS) Receives $52.59 Consensus PT from Brokerages

Doximity, Inc. (NASDAQ:DOCS) has been assigned an average rating of “Hold” from the twenty brokerages that are covering the company, MarketBeat Ratings reports. Thirteen investment analysts have rated the stock with a hold recommendation, six have assigned a buy recommendation and one has given a strong buy recommendation to the company. The average 1 year price target among analysts that have issued ratings on the stock in the last year is $52.59.

A number of research analysts recently weighed in on DOCS shares. JPMorgan Chase & Co. raised their price target on shares of Doximity from $30.00 to $48.00 and gave the company a “neutral” rating in a research report on Thursday, November 21st. KeyCorp upgraded Doximity from a “sector weight” rating to an “overweight” rating and set a $70.00 target price on the stock in a research note on Friday, November 8th. Raymond James reaffirmed an “outperform” rating and set a $65.00 price target (up from $37.00) on shares of Doximity in a research report on Friday, November 8th. Baird R W upgraded Doximity to a “strong-buy” rating in a report on Tuesday, September 17th. Finally, Wells Fargo & Company upgraded Doximity from an “underweight” rating to an “equal weight” rating and upped their price objective for the company from $19.00 to $41.00 in a research note on Friday, November 8th.

Doximity Trading Up 0.3 %

Shares of NASDAQ:DOCS opened at $53.56 on Friday. The stock has a market cap of $10.00 billion, a PE ratio of 61.56, a price-to-earnings-growth ratio of 4.16 and a beta of 1.40. The stock’s fifty day simple moving average is $51.29 and its two-hundred day simple moving average is $40.37. Doximity has a 1-year low of $22.96 and a 1-year high of $61.75.

Hedge Funds Weigh In On Doximity

Large investors have recently made changes to their positions in the stock. MetLife Investment Management LLC raised its stake in shares of Doximity by 0.6% during the 3rd quarter. MetLife Investment Management LLC now owns 65,064 shares of the company’s stock valued at $2,835,000 after purchasing an additional 363 shares during the period. First Horizon Advisors Inc. increased its position in shares of Doximity by 22.5% during the third quarter. First Horizon Advisors Inc. now owns 2,094 shares of the company’s stock valued at $91,000 after buying an additional 384 shares during the period. GAMMA Investing LLC lifted its holdings in shares of Doximity by 40.1% in the third quarter. GAMMA Investing LLC now owns 1,439 shares of the company’s stock worth $63,000 after buying an additional 412 shares in the last quarter. Van ECK Associates Corp lifted its holdings in shares of Doximity by 19.7% in the second quarter. Van ECK Associates Corp now owns 2,590 shares of the company’s stock worth $72,000 after buying an additional 427 shares in the last quarter. Finally, Cornercap Investment Counsel Inc. grew its stake in Doximity by 3.2% during the second quarter. Cornercap Investment Counsel Inc. now owns 17,143 shares of the company’s stock valued at $479,000 after acquiring an additional 537 shares in the last quarter. 87.19% of the stock is owned by institutional investors.

About Doximity

Doximity, Inc operates a cloud-based digital platform for medical professionals in the United States. The company's platform provides its members with tools built for medical professionals, enabling them to collaborate with their colleagues, coordinate patient care, conduct virtual patient visits, stay up to date with the latest medical news and research, and manage their careers.